Drug–DNA interactions: Spectroscopic and footprinting studies of site and sequence specificity of elliptinium
Authors:
- 5 October 1991
- journal article
- research article
- Published by Wiley in Biopolymers
- Vol. 31 (11) , 1325-1341
Abstract
The binding of the antitumoral ellipticine derivative 2-methyl-9-hydroxyellipticinium acetate (elliptinium; NMHE) to DNA was analyzed by the combined use of DNase I foot-printing and spectroscopic methods. Using two fragments of pBR322 DNA, five discrete NMHE binding sites of 5–7 protected base pairs (bp) were detected by footprinting at 4°C on the analyzed regions. These corresponded to alternating pyrimidines and purines. The inactive derivative 2-methyl ellipticinium acetate L(NME) lacking a hydroxy group failed to demonstrate DNA protection even at low temperature. Ultraviolet-absorption and 1H-nmr analysis was performed using two autocomplementary octanucleotides d(TGACGTCA) (I) and d(ACTGCAGT) (II). The uv-absorption titrations resulted in an intercalative binding mode for NMHE in the oligomers. Analysis of the derived biphasic Scatchard plots yielded two binding sites corresponding to ∼6-bp and 2-bp sizes and characterized by apparent association constants K1 ∼ 108M−1 and K2 ∼ 106M−1, respectively. The 1H-nmr analysis of exchangeable (imino) protons and nonexchangeable protons performed in the one- and two-dimensional modes confirmed the intercalation of NMHE, and further revealed the existence of multiple sites on DNA. Assuming that imino resonance line width concerned the sole kinetic effects, 10-ms order lifetimes were estimated for the drug–oligonucleotide complexes at 7°C, pH 7, and 0.1 ionic strength. Finally examination of every drug–DNA spectra in the light of the footprinting results indicated that there was a preference for binding of NMHE to the CpG (octamer I) and TpG (octamers I and II) steps.Keywords
This publication has 53 references indexed in Scilit:
- Footprinting analysis of sequence-specific DNA-drug interactionsChemico-Biological Interactions, 1989
- Conformational variations in d(TGACGTCA) and its reverse sequence d(ACTGCAGT): A joint circular dichroism and nuclear magnetic resonance studyBiochemical and Biophysical Research Communications, 1989
- Sequence-dependent variations in the phosphorus-31 NMR spectra and backbone torsional angles of wild-type and mutant lac operator fragmentsBiochemistry, 1989
- Assignments of phosphorus-31 NMR resonances in oligodeoxyribonucleotides: origin of sequence-specific variations in the deoxyribose phosphate backbone conformation and the phosphorus-31 chemical shifts of double-helical nucleic acidsBiochemistry, 1988
- Elliptinium, a DNA intercalating agent with broad antitumor activity in a human tumor cloning systemEuropean Journal of Cancer and Clinical Oncology, 1987
- Proton NMR study of the binding of bis(acridines) to d(AT)5.cntdot.d(AT)5. 2. Dynamic aspectsBiochemistry, 1985
- Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteinsBiochemical and Biophysical Research Communications, 1983
- Structure of a B-DNA dodecamerJournal of Molecular Biology, 1981
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancers1978
- Alkaloids of Ochrosia elliptica Labill.1Journal of the American Chemical Society, 1959